EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Nanotechnology-Enhanced Controlled Release Systems in Topical Therapeutics

Yohannes Teklehaimanot

Precision Nanomedicine · 2024

DOI: 10.33218/001c.127336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Nanomedicine, 2024. Verfasst von Yohannes Teklehaimanot. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topical and transdermal drug delivery are alternative routes for medications facing challenges like solubility, stability, and first-pass metabolism. However, conventional immediate-release dosage forms delivered topically have drawbacks, including poor penetration and high side ef-fects. Controlled-release nanoparticles offer a promising solution, improving drug permeation and providing controlled release. This review examines recent advances, challenges, and prospects of controlled-release nanoparticles for topical drug delivery. Various types of nanoparticles, including lipid nanoparticles, nanoemulsions, nanoemulgels, cubosome liposomes, poly-meric nanoparticles, solid-lipid nanoparticles, lipid-polymer hybrid nanoparticles, and nanostructured lipid carriers, carbon nanotubes, nanocomposites, and protein nanoparticles have been explored for their ability to encapsulate drugs, prolong drug release, and enhance skin permeation as well as improve therapeutic outcomes. Studies have demonstrated the effectiveness of these nanoparticles in improving sustained and controlled-release topical delivery of a wide range of drugs, including poorly soluble, low degree of skin penetration, low stability, and drugs with low bioavailability and biological products. Despite their potential benefits, challenges such as scalability, reproducibility, and safety concerns remain. Future research should ad-dress these challenges and explore novel strategies to improve efficacy and safety by converging with microneedles and 3D nanoparticles. Ultimately, controlled-release nanoparticles have the potential to revolutionize dermatological and transdermal drug delivery, leading to improved therapeutic outcomes and patient care.

Zitieren

APA

Teklehaimanot, Y. (2024). Nanotechnology-Enhanced Controlled Release Systems in Topical Therapeutics. Precision Nanomedicine. https://doi.org/10.33218/001c.127336

Vancouver

Teklehaimanot Y. Nanotechnology-Enhanced Controlled Release Systems in Topical Therapeutics. Precision Nanomedicine. 2024. doi:10.33218/001c.127336

BibTeX
@article{Teklehaimanot2024,
  author = {Teklehaimanot, Yohannes},
  title = {Nanotechnology-Enhanced Controlled Release Systems in Topical Therapeutics},
  journal = {Precision Nanomedicine},
  year = {2024},
  doi = {10.33218/001c.127336}
}
Kostenlos starten →